GSK
Chinese government to lift drug price controls
May 5, 2015Sales and Marketing China, Drug pricing, GSK, IMS, Xarelto, government
The Chinese government has announced that it will remove price caps for most medicines and allow the market to play …
GSK sees FDA clearance for asthma drug
May 1, 2015Sales and Marketing Breo Ellipta, FDA, GSK, Theravance
GlaxoSmithKline and Theravance’s Breo Ellipta inhaler has been approved by the FDA to treat asthma in adults. Whilst the once-daily treatment …
GSK shingles vaccine performs
April 29, 2015Research and Development, Sales and Marketing GSK, GlaxoSmithKline, HZ/su, Merck, zostovax
GlaxoSmithKline’s HZ/su vaccine candidate for the prevention of shingles has demonstrated promising benefits across all age groups in a late-stage …
Novartis and Abbott start year with strong Q1 sales
April 23, 2015Sales and Marketing Abbott, Amgen, Cosentyx, GSK, Neupogen, Novartis, Secukinumab, Zarxio, biosimilar, filgrastim, financials
Novartis and Abbott have both posted strong first-quarter results and made bullish predictions about their financial performance in 2015. Novartis …
GSK sees further US job losses following Novartis deal
April 17, 2015Research and Development, Sales and Marketing GSK, Jobs, Novartis, cuts, merger, pittsburgh, restructuring
Hundreds more jobs are at risk within GlaxoSmithKline as the fallout from the company’s asset-swapping deal with Novartis continues. Staff …
Hundreds of jobs threatened after big pharma deals close
April 7, 2015Medical Communications, Research and Development, Sales and Marketing Deals, GSK, Jobs, Novartis, US, Valeant, job losses, redundancy, salix
Fresh from deals worth a combined $34 billion, GSK and Salix Pharmaceuticals have announced company restructures that have placed more …
Working Life: GlaxoSmithKline’s Thomas Webb
April 2, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Hong Kong, Working Life, macau, oncology, thomas webb
Thomas Webb, launch lead for GSK oncology Hong Kong and Macau How did you find your way into your current role? …
GSK and UK government agree meningitis B vaccine deal
March 30, 2015Sales and Marketing AstraZeneca, Bexsero, GSK, Novartis, meningitis v, vaccines
The UK government has agreed a deal with GlaxoSmithKline to provide its meningitis B vaccine Bexsero on the NHS, after …
Big pharma teams with government on genomic research
March 27, 2015Research and Development, Sales and Marketing AbbVie, Alexion Pharmaceuticals, AstraZeneca, Biogen, Cameron, Dimension Therapeutics, GSK, Genomic, Genomics england, Helomics, Roche, Takeda, UCB, UK, genomes
Ten firms will partner up with Genomics England to develop new diagnostics and treatments for people with rare diseases and …
GSK seeks development proposals from academics
March 25, 2015Research and Development, Sales and Marketing GSK, academics, fast track challenge, proposals
Registration has opened for GlaxoSmithKline’s third annual Discovery Fast Track challenge, which sees the company searching for new drug discovery …
GSK and Theravance see FDA nod for asthma indication
March 20, 2015Sales and Marketing Advair, AstraZeneca, Dulera, FDA, Foradil, GSK, Merck, Symbicort, Theravance, asthma, breo, budesonide/formoterol fumarate dihydratem, ellipta, fluticasone propionate, formoterol fumarate, mometasone/formoterol
An FDA panel has recommended the approval of asthma treatment Breo Ellipta in adults – but voted against supporting its …
GSK premature babies drug starts late-stage trials
March 18, 2015Sales and Marketing GSK, Retosiban, atosiban, babies, birth, oxytocin, premature
GlaxoSmithKline has initiated Phase III studies to evaluate the safety and efficacy of an investigational treatment for babies born prematurely. …
Big pharma partners with government over $100m dementia fund
March 17, 2015Research and Development, Sales and Marketing Alzheimer's, Biogen IDEC, GSK, J&J, JJ, Pfizer, government, jp morgan, lilly
Lilly, Pfizer, GSK, J&J and Biogen Idec are set to join a $100m Dementia Discovery Fund to boost research into …
GSK sells off stake in Aspen for $853m
March 13, 2015Sales and Marketing Africa, China, GSK, Novartis, Singapore, aspen, merger, redfern
GlaxoSmithKline has sold off half its stake in South Africa’s Aspen Pharmacare in a move that will net the British …
GSK picks Singapore for Asian hub
March 12, 2015Manufacturing and Production, Research and Development, Sales and Marketing Asia, GSK, Singapore, Takeda, Witty, emerging markets
Despite GlaxoSmithKline’s ongoing troubles in Asia it has decided to establish a new HQ in Singapore to bolster its presence …
Latest content
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership
